Abstract:BACKGROUND:Primary ovarian insufficiency (POI) is characterized by marked heterogeneity, but with a significant genetic contribution. Identifying exact causative genes has been challenging, with many discoveries not replicated. It is timely to take stock of the field, outlining the progress made, framing the controversies and anticipating future directions in elucidating the genetics of POI. METHODS:A search for original articles published up to May 2015 was performed using PubMed and Google Scholar, identifying studies on the genetic etiology of POI. Studies were included if chromosomal analysis, candidate gene screening and a genome-wide study were conducted. Articles identified were restricted to English language full-text papers. RESULTS:Chromosomal abnormalities have long been recognized as a frequent cause of POI, with a currently estimated prevalence of 10-13%. Using the traditional karyotype methodology, monosomy X, mosaicism, X chromosome deletions and rearrangements, X-autosome translocations, and isochromosomes have been detected. Based on candidate gene studies, single gene perturbations unequivocally having a deleterious effect in at least one population include Bone morphogenetic protein 15 (BMP15), Progesterone receptor membrane component 1 (PGRMC1), and Fragile X mental retardation 1 (FMR1) premutation on the X chromosome; Growth differentiation factor 9 (GDF9), Folliculogenesis specific bHLH transcription factor (FIGLA), Newborn ovary homeobox gene (NOBOX), Nuclear receptor subfamily 5, group A, member 1 (NR5A1) and Nanos homolog 3 (NANOS3) seem likely as well, but mostly being found in no more than 1-2% of a single population studied. Whole genome approaches have utilized genome-wide association studies (GWAS) to reveal loci not predicted on the basis of a candidate gene, but it remains difficult to locate causative genes and susceptible loci were not always replicated. Cytogenomic methods (array CGH) have identified other regions of interest but studies have not shown consistent results, the resolution of arrays has varied and replication is uncommon. Whole-exome sequencing in non-syndromic POI kindreds has only recently begun, revealing mutations in the Stromal antigen 3 (STAG3), Synaptonemal complex central element 1 (SYCE1), minichromosome maintenance complex component 8 and 9 (MCM8, MCM9) and ATP-dependent DNA helicase homolog (HFM1) genes. Given the slow progress in candidate-gene analysis and relatively small sample sizes available for GWAS, family-based whole exome and whole genome sequencing appear to be the most promising approaches for detecting potential genes responsible for POI. CONCLUSION:Taken together, the cytogenetic, cytogenomic (array CGH) and exome sequencing approaches have revealed a genetic causation in ∼20-25% of POI cases. Uncovering the remainder of the causative genes will be facilitated not only by whole genome approaches involving larger cohorts in multiple populations but also incorporating environmental exposures and exploring signaling pathways in intragenic and intergenic regions that point to perturbations in regulatory genes and networks.

Relationship between polymorphisms of bone morphogenetic protein 15 gene and premature ovarian insufficiency: a meta-analysis update

Identification of novel biallelic variants in BMP15 in two siblings with premature ovarian insufficiency

An Update on Primary Ovarian Insufficiency

Sequence Variants in Exons of the Bmp-15 Gene in Chinese Patients with Premature Ovarian Failure

Association of Polymorphisms in FSHR, ESR1, and BMP15 with Primary Ovarian Insufficiency and Meta-Analysis

Association between TGF-β/BMP signaling pathway polymorphisms and the risk of primary ovarian insufficiency in Korean women

A Novel Homozygous Mutation of Bone Morphogenetic Protein 15 Identified in a Consanguineous Marriage Family with Primary Ovarian Insufficiency.

Landscape of pathogenic mutations in premature ovarian insufficiency

Novel bone morphogenetic protein 15 (BMP15) gene variants implicated in premature ovarian insufficiency

Genetic insights into the complexity of premature ovarian insufficiency

Association Between Bone Morphogenetic Protein and Ossification of Posterior Longitudinal Ligament : a Meta-Analysis

The Role of BMP15 and GDF9 in the Pathogenesis of Primary Ovarian Insufficiency

Positive Selection in Bone Morphogenetic Protein 15 Targets a Natural Mutation Associated with Primary Ovarian Insufficiency in Human

Genetics of primary ovarian insufficiency: new developments and opportunities.

Bone morphogenetic protein-15 in follicle fluid combined with age may differentiate between successful and unsuccessful poor ovarian responders

Selected Genetic Factors Associated with Primary Ovarian Insufficiency

OR31-06 Candidate Gene Variants in a Large Cohort of Women with Primary Ovarian Insufficiency

DNA double-strand break genetic variants in patients with premature ovarian insufficiency

Two Novel Biallelic Mutations in PSMC3IP in a Chinese Patient Affected by Primary Ovarian Insufficiency: Case Report and Review of the Literature

Association of Variants in Vascular Endothelial Growth Factor A Gene and <i>VEGFA</i> Serum Levels with the Risk of Primary Ovarian Insufficiency: A Case-Control Study

Mechanism Exploration of Environmental Pollutants on Premature Ovarian Insufficiency: a Systematic Review and Meta-analysis